In vivo studies have shown that insulin/IGF-1 can promote angiogenesis and provide nutrition for bone formation [10-12]
UHCs 2026 commercial PA criteria for Wegovy require five elements: BMI of 30 or higher, or BMI 27 to 29.9 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, OSA, CVD), documentation of a structured weight management program for at least 6 months in the past 24 months, prescriber attestation that lifestyle changes alone have been inadequate, age 18 or older, and concurrent reduced-calorie diet and physical activity
Salvadori, G., Mirisola, M
Thats a nice problem to have
10.3389/bjbs.2023.10794 164 YaoW.HuoJ.JiJ.LiuK.TaoP
Endocrine 68, 518525